Immunomet Therapeutics, Inc. research brief

CIK 2109829 Copy CIK

Generated Nov. 4, 2026, 4:49 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: HOUSTON TX. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Feb. 5, 2026 · D · 0002109829-26-000001 · Source evidence

  Reported offering amount: 10000000 USD. Reported amount sold: 842211 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Immunomet Therapeutics, Inc. research brief,” CIK 2109829, retrieved Nov. 4, 2026, 4:49 a.m.. Cite the specific accessions used. No amounts have been summed.